Women's Health Beliefs and Intention to Use Chemoprevention for Breast Cancer

被引:0
|
作者
Keller, Kristin G. [1 ]
Toriola, Adetunji T. [2 ]
Schneider, Joanne Kraenzle [3 ]
机构
[1] St Louis Univ, Trudy Busch Valentine Sch Nursing, St Louis, MO 63103 USA
[2] Washington Univ, Div Publ Hlth Sci, Mary Culver Dept Surg, Alvin J Siteman Canc Ctr,Sch Med,Surg, St Louis, MO USA
[3] Trudy Busch Valentine Sch Nursing, St Louis, MO USA
基金
美国国家卫生研究院;
关键词
breast cancer; chemoprevention; health beliefs; mammography; INCREASED RISK; MAMMOGRAPHY; PREVENTION; TAMOXIFEN; FATALISM; SCALE; INTERVENTIONS; PREFERENCES; PERCEPTIONS; MODULATORS;
D O I
10.1188/23.ONF.611-623
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
OBJECTIVES: To investigate the associations between women's health beliefs and their intention to use chemoprevention. SAMPLE & SETTING: Participants were postmenopausal women (N = 400) aged 50-64 years who were recruited for a study on mammographic breast density. METHODS & VARIABLES: Participants completed a screening mammogram and breast cancer health belief questionnaires. The authors regressed intention to use chemoprevention onto health belief scores (breast cancer fatalism, fear, perceived threat, perceived benefits, barriers, and self-efficacy). RESULTS: Nearly half of the participants indicated that they would be interested in using chemoprevention if they were found to be at high risk for developing breast cancer. Women who reported higher perceived benefits of chemoprevention, higher perceptions of their ability to use chemoprevention (self-efficacy), and fewer logistic barriers to seeking health care had significantly higher intention to use chemoprevention. IMPLICATIONS FOR NURSING: Interventions aimed at reducing logistic barriers to health care may increase the uptake of chemoprevention among at-risk women. In addition, women at the time of mammography and women with higher levels of education may be motivated to consider using chemoprevention.
引用
收藏
页码:611 / 623
页数:13
相关论文
共 50 条
  • [41] The molecular basis of retinoids' use in breast cancer chemoprevention
    Karamouzis, Michalis V.
    Konstantinopoulos, Panagiotis A.
    Papavassiliou, Athanasios G.
    CELLULAR ONCOLOGY, 2007, 29 (03) : 183 - 184
  • [42] Tamoxifen eligibility, net benefit and use for breast cancer chemoprevention among white women in the US
    Freedman, AN
    Graubard, BI
    Rao, RS
    McCaskill-Stevens, W
    Ballard-Barbash, R
    Gail, MH
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2003, 12 (11) : 1314S - 1314S
  • [43] Use of Calcium Channel Blockers and Breast Cancer Risk in the Women's Health Initiative
    Brasky, Theodore M.
    Krok-Schoen, Jessica L.
    Liu, Jingmin
    Chlebowski, Rowan T.
    Freudenheim, Jo L.
    Lavasani, Sayeh
    Margolis, Karen L.
    Qi, Lihong
    Reding, Kerryn W.
    Shields, Peter G.
    Simon, Michael S.
    Wactawski-Wende, Jean
    Wang, Ange
    Womack, Catherine
    Manson, JoAnn E.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2017, 26 (08) : 1345 - 1348
  • [44] Statin use and breast cancer: Prospective results from the Women's Health Initiative
    Cauley, JA
    McTiernan, A
    Rodabough, RJ
    LaCroix, A
    Bauer, DC
    Margolis, KL
    Paskett, ED
    Vitolins, MZ
    Furberg, CD
    Chlebowski, RT
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2006, 98 (10) : 700 - 707
  • [45] Use of oral contraceptives and breast cancer risk: the women's lifestyle and health study
    Kumle, M
    Weiderpass, E
    Braaten, T
    Adami, HO
    Persson, I
    Lund, E
    EUROPEAN JOURNAL OF CANCER, 2002, 38 : S165 - S165
  • [46] Alcohol Use and Breast Cancer Survival among Participants in the Women's Health Initiative
    Lowry, Sarah J.
    Kapphahn, Kris
    Chlebowski, Rowan
    Li, Christopher I.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2016, 25 (08) : 1268 - 1273
  • [47] Hair product use and breast cancer incidence in the Black Women's Health Study
    Coogan, Patricia F.
    Rosenberg, Lynn
    Palmer, Julie R.
    Cozier, Yvette C.
    Lenzy, Yolanda M.
    Bertrand, Kimberly A.
    CARCINOGENESIS, 2021, 42 (07) : 924 - 930
  • [48] Use of tamoxifen and raloxifene for breast cancer chemoprevention in 2010
    Waters, Erika A.
    McNeel, Timothy S.
    Stevens, Worta McCaskill
    Freedman, Andrew N.
    BREAST CANCER RESEARCH AND TREATMENT, 2012, 134 (02) : 875 - 880
  • [49] Early breast cancer detection practices, health beliefs, and cancer worries in Jewish and Arab women
    Cohen, M
    Azaiza, F
    PREVENTIVE MEDICINE, 2005, 41 (5-6) : 852 - 858
  • [50] Early breast cancer detection practices, health beliefs and cancer worries in Jewish and Arab women
    Cohen, M.
    Azaiza, F.
    PSYCHO-ONCOLOGY, 2006, 15 (02) : S204 - S204